Trials / Completed
CompletedNCT04425889
COVID-19 Antibodies Among Healthcare Workers
Prevalence of SARS-CoV-2 Antibodies Among Healthcare Workers in a COVID-19 Unit
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 156 (actual)
- Sponsor
- Hospital Universitario Dr. Jose E. Gonzalez · Academic / Other
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Accepted
Summary
Observational, point of prevalence study determining the presence of anti-SARS-CoV-2 antibody
Detailed description
All Healthcare workers (HCW) who had entered contaminated areas at least once and that 14 days or more had passed from their first entrance to contaminated areas were included. They were classified as asymptomatic and pauci-symptomatic. A COVID-19 IgG/IgM rapid test was used for antibody detection, and selected participants were subject to real time polymerase chain reaction (qPCR) for SARS-CoV-2.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | COVID-19 IgG/IgM Rapid Test Cassette test (Healgen Scientific, Houston, Texas, USA) | a blood sample is drained for detection of IgG and IgM antibody |
Timeline
- Start date
- 2020-05-05
- Primary completion
- 2020-05-30
- Completion
- 2020-06-01
- First posted
- 2020-06-11
- Last updated
- 2020-06-12
Locations
1 site across 1 country: Mexico
Source: ClinicalTrials.gov record NCT04425889. Inclusion in this directory is not an endorsement.